PBX-004

N/A

Report date: 2023/12/01 15:34:38

Base Information

Drug NamePBX-004

Drug Alias NamePBX-004

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionFibroblast growth factor receptor 2 antagonists

TargetsFibroblast growth factor receptor 2

Therapy Area/IndicationsStomach NeoplasmsBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPinotbio Inc

China Registration ClassN/A

Active CompaniesPinotbio Inc

Inactive CompaniesN/A

Active IndicationsStomach NeoplasmsBiliary Tract Neoplasms

Inactive IndicationsN/A

ATC CodeN/A